ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,002.77
-0.12%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) Noticias

HRTX

Heron Therapeautics (HRTX)

Heron Therapeautics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HRTX
FechaHoraFuenteTítuloSímboloCompañía
07/05/202407:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRTXHeron Therapeautics Inc
07/05/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
07/05/202407:00PR Newswire (US)Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
24/04/202407:00PR Newswire (US)Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:HRTXHeron Therapeautics Inc
11/04/202415:05PR Newswire (US)Heron Therapeutics to Host Investor Day on May 15, 2024 in New York CityNASDAQ:HRTXHeron Therapeautics Inc
28/03/202415:05PR Newswire (US)Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:HRTXHeron Therapeautics Inc
13/03/202415:25AllPennyStocks.comBiotech Finds Mid-Week Success Following Q4 Earnings ReleaseNASDAQ:HRTXHeron Therapeautics Inc
12/03/202415:05PR Newswire (US)Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
12/03/202406:22IH Market NewsGlobal Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market TradingNASDAQ:HRTXHeron Therapeautics Inc
28/02/202407:00PR Newswire (US)Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
14/02/202415:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
24/01/202408:25AllPennyStocks.comPremarket Heats Up For Biotech Before Opening BellNASDAQ:HRTXHeron Therapeautics Inc
23/01/202419:00PR Newswire (US)Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue ProceduresNASDAQ:HRTXHeron Therapeautics Inc
19/01/202420:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
07/01/202416:00PR Newswire (US)Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative PainNASDAQ:HRTXHeron Therapeautics Inc
15/11/202311:25AllPennyStocks.comBiotech Shares Up Sharply Following Quarterly ResultsNASDAQ:HRTXHeron Therapeautics Inc
14/11/202315:05PR Newswire (US)Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
07/11/202315:05PR Newswire (US)Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023NASDAQ:HRTXHeron Therapeautics Inc
23/08/202315:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:HRTXHeron Therapeautics Inc
14/08/202315:05PR Newswire (US)Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
07/08/202315:05PR Newswire (US)Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:HRTXHeron Therapeautics Inc
01/08/202312:56Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HRTXHeron Therapeautics Inc
25/07/202315:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
25/07/202315:13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
24/07/202308:02PR Newswire (US)Heron Therapeutics Announces Cost Reduction Plan and RestructuringNASDAQ:HRTXHeron Therapeautics Inc
24/07/202308:00PR Newswire (US)Heron Therapeutics Announces $30 Million Private Placement FinancingNASDAQ:HRTXHeron Therapeautics Inc
30/06/202315:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRTXHeron Therapeautics Inc
23/06/202315:29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HRTXHeron Therapeautics Inc
23/06/202315:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HRTXHeron Therapeautics Inc
23/06/202315:05PR Newswire (US)Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial OfficerNASDAQ:HRTXHeron Therapeautics Inc
 Showing the most relevant articles for your search:NASDAQ:HRTX

Su Consulta Reciente

NASDAQ
NVDA
NVIDIA
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDMXN
US Dollar vs MXN
CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados